Proliferative vitreoretinopathy - Developments in adjunctive treatment and retinal pathology

172Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Proliferative vitreoretinopathy (PVR) remains a difficult management problem despite advances in vitreoretinal surgery. There is still a significant incidence of PVR in rhegmatogenous retinal detachment and other forms of retinal disease. Surgery for PVR now has a high anatomical success rate although visual results are often disappointing. The use of adjunctive treatments to prevent cellular proliferation holds promise for the prevention of PVR or recurrences after surgery. Control of proliferation and strategies aimed at improving visual outcome are important areas of future research in PVR and other forms of retinal disease. Studies of the intraretinal and peri-retinal pathology of PVR have demonstrated characteristic changes which may have a significant influence on visual outcome and surgical management.

Cite

CITATION STYLE

APA

Charteris, D. G., Sethi, C. S., Lewis, G. P., & Fisher, S. K. (2002). Proliferative vitreoretinopathy - Developments in adjunctive treatment and retinal pathology. Eye, 16(4), 369–374. https://doi.org/10.1038/sj.eye.6700194

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free